Back to Search
Start Over
155Tb production by cyclotrons: what level of 155Gd enrichment allows clinical applications?
- Source :
- EJNMMI Physics; 3/15/2024, Vol. 11 Issue 1, p1-20, 20p
- Publication Year :
- 2024
-
Abstract
- Background: <superscript>155</superscript>Tb represents a potentially useful radionuclide for diagnostic medical applications, but its production remains a challenging problem, in spite of the fact that many production routes have been already investigated and tested. A recent experimental campaign, conducted with low-energy proton beams impinging on a <superscript>155</superscript>Gd target with 91.9% enrichment, demonstrated a significant co-production of <superscript>156g</superscript>Tb, a contaminant of great concern since its half-life is comparable to that of <superscript>155</superscript>Tb and its high-energy γ emissions severely impact on the dose released and on the quality of the SPECT images. In the present investigation, the isotopic purity of the enriched <superscript>155</superscript>Gd target necessary to minimize the co-production of contaminant radioisotopes, in particular <superscript>156g</superscript>Tb, was explored using various computational simulations. Results: Starting from the recent experimental data obtained with a 91.9% <superscript>155</superscript>Gd-enriched target, the co-production of other Tb radioisotopes besides <superscript>155</superscript>Tb has been theoretically evaluated using the Talys code. It was found that <superscript>156</superscript>Gd, with an isotopic content of 5.87%, was the principal contributor to the co-production of <superscript>156g</superscript>Tb. The analysis also demonstrated that the maximum amount of <superscript>156</superscript>Gd admissible for <superscript>155</superscript>Tb production with a radionuclidic purity higher than 99% was 1%. A less stringent condition was obtained through computational dosimetry analysis, suggesting that a 2% content of <superscript>156</superscript>Gd in the target can be tolerated to limit the dose increase to the patient below the 10% limit. Moreover, it has been demonstrated that the imaging properties of the produced <superscript>155</superscript>Tb are not severely affected by this level of impurity in the target. Conclusions: <superscript>155</superscript>Tb can be produced with a quality suitable for medical applications using low-energy proton beams and <superscript>155</superscript>Gd-enriched targets, if the <superscript>156</superscript>Gd impurity content does not exceed 2%. Under these conditions, the dose increase due to the presence of contaminant radioisotopes remains below the 10% limit and good quality images, comparable to those of <superscript>111</superscript>In, are guaranteed. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 21977364
- Volume :
- 11
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- EJNMMI Physics
- Publication Type :
- Academic Journal
- Accession number :
- 176460072
- Full Text :
- https://doi.org/10.1186/s40658-024-00630-6